Short CV/Education and training

  • 1974 – 1981
    Studied chemistry and pharmacy at Marburg University and Kiel University

  • 1990 – 1999
    C3 professor at the University of Bonn, Germany

  • 1994 – 1995
    Visiting professor at the University of Erlangen-Nuremberg, Germany, and the University of Illinois at Chicago, USA

  • 1997 – 1999
    Vice-rector for teaching, studies and study reform at the University of Bonn

  • Since 1999
    C4/W3 professor of pharmaceutical chemistry at the University of Würzburg, Germany

  • Since 2009
    Dean of the Faculty of Chemistry and Pharmacy at the University of Würzburg

Selected publications

  • Mohr, K. et al.: Rational design of dualsteric GPCR ligands: quests and promise. In: Br. J. Pharmacol. 159, 2010. pp. 997-1008.

  • Antony, J. et al.: Dualsteric GPCR targeting: a novel route to binding and signalling pathway selectivity. In: FASEB J. 23, 2009. pp. 442-450 (Listed as a "Must Read" by the "Faculty of 1000 Biology – the expert guide to the most important advances in biology").

  • Niedermeier, S. et al.: A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. In: J. Med. Chem. 52, 2009. pp. 4257-4265.

  • Göbel, T. et al.: In search of novel agents for therapy of tropical diseases and human immunodeficiency virus. In: J. Med. Chem. 51, 2008. pp. 238-250.

  • Hörr, V. et al.: Laser-induced fluorescence-capillary electrophoresis and fluorescence microplate reader measurement: two methods to quantify the effect of antibiotics. In: Anal. Chem. 79, 2007. pp. 7510-7518 (reviewed by D.L. Shenkenberg in Biophotonics International, Dec. 2007, pp. 57-58).

  • Disingrini, T. et al.: Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors. In: J. Med. Chem. 49, 2006. pp. 366-372.

Selected projects

  • Characterisation of the oncogenic signalling network in multiple myeloma: development of targeted therapies, clinical research group KFO 216, inhibitors of the HSF/HSP system for treating multiple myeloma, since 2009

  • Identification, preparation and functional analysis of active ingredients for combating infectious diseases, SFB 630, small molecules for treating tropical infectious diseases, since 2003

  • Allosteric modulators and subtype-selective ligands of the muscarinic receptors, since 1991

Membership in scientific bodies/juries

  • German Research Foundation (DFG) review-board member at the University of Würzburg, Germany, since 2009

  • Member of the Board of Pharmaceutical Science, International Federation of Pharmacy (FIP), since 2008

  • Member of the executive committee, European Federation for Pharmaceutical Sciences (Eufeps), since 2007

  • President of the German Pharmaceutical Society, 2004 – 2007

  • Member of the board of trustees of the University of Bonn, Germany, 2003 – 2007

  • Member of the scientific advisory board, German Federal Institute for Drugs and Medical Devices (BfArM), since 2002

  • Member of the German and European pharmacopoeia commissions, as well as president of several German and European pharmacopoeia boards, since 2001


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

Follow us

Similar profiles

  1. Dr. Fatemeh Ajalloueian

    Physical sciences, Biopolymers, Fiber science

  2. Dr. Cristina Afonso

    Physical sciences

  3. Prof. Dr. Katharina Al-Shamery

    Physical sciences, Surface and interface science, (photo)catalysis and nanophotonics

  4. Prof. Dr. Núria Aliaga-Alcalde

    Physical sciences, Chemistry coordination, Chemistry, Molecular magnetism, Molecular electronics, Bioinorganics



  1. Beware of 'Miracle' Powders

    Patients suffering from chronic diseases sometimes pin their hopes on 'herbal' remedies. Pharmacists from the University of Würzburg have now analysed one of these 'miracle' drugs – with alarming results.

  2. Fine Regulation of Receptors Achieved

    A large number of drugs for cardiac insufficiency, high blood pressure and other conditions regulate the function of receptors. Researchers from Würzburg, Bonn and Milan have designed new agents for novel fine adjustments of these receptors.

  3. New Agent Against Tropical Parasite

    There is an urgent demand for better drugs to treat the African sleeping sickness. Scientists of Würzburg University, among them the research group of professor Ulrike Holzgrabe, have now developed a very promising new agent.

  4. From Tropical Diseases to Counterfeit Drugs: The Diversity of Medicinal Chemistry

    The professor of medicinal and pharmaceutical chemistry at the Würzburg University develops active ingredients for medicines, detects counterfeit drugs and helps to fight infectious diseases.

Academia Net